Assessment of the Relative Clinical Utility of Sufentanil and Morphine Administered by Patient Controlled Analgesia Pumps Following Abdominal Hysterectomy

REFERENCES

• Bennett R L, Batenhorst R L, Bivins B A, et al. Patient-controlled analgesia: A new concept of postoperative pain relief. Ann Surg 1982; 195: 700–705
   PubMed Web of Science ®Google Scholar
• White P F. Use of patient-controlled analgesia for the management of acute pain. JAMA 1988; 259: 243–247
   PubMed Web of Science ®Google Scholar
• Hill H F, Chapman C R, Kornell J A, Sullivan K M, Saeger L C, Benedetti C. Self administration of morphine into bone marrow transplant patients reduces drug requirement. Pain 1990; 40: 121–129
   PubMed Web of Science ®Google Scholar
• Bahar M, Rosen M, Vickers M D. Self-administered nalbuphine, morphine and pethidine. Anaesthesia 1985; 40: 529–532
   PubMed Web of Science ®Google Scholar
• Ginsberg B, Gil K M, Muir M R, Sullivan F, Williams D A, Glass P SA. The influence of lockout interval and drug selection on patient controlled analgesia following gynecological surgery. Pain 1995; 62: 95–100
   PubMed Web of Science ®Google Scholar
• Gil K M, Ginsberg B, Muir M, Sykes D, Williams D A. Patient controlled analgesia in post operative pain: The relation of psychological factors to pain and analgesic use. Clin J Pain 1990; 6: 137–142
   PubMed Web of Science ®Google Scholar
• Dahlstrom B, Tamsen A, Paalzow L, Hartvig P. Patient controlled analgesic therapy part N: Pharmacokinetics and analgesic plasma concentrations of morphine. Clin Pharmacokinet 1982; 7: 266–279
   PubMed Web of Science ®Google Scholar
• Tamsen A, Hartvig P, Fagerland C, Dahlstrom B. Patient-controlled analgesic therapy, part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain. Clin Pharmacokinet 1982; 8: 164–175, 7
   Google Scholar
• Whitehead E M, O'Sullivan G M, Lloyd J, Bullingham R ES. A new method for rate of analgesic onset: Two doses of intravenous morphine compared with placebo. Clin Pharmacol Ther 1992; 52: 197–204
   PubMed Web of Science ®Google Scholar
• Sinatra R S, Lodge K, Sibert K, Chung S, Chung J H, Parker A, Harrison D M. A comparison of morphine, meperidine and oxymorphone as utilized in patient controlled analgesia following cesarean delivery. Anesthesiology 1990; 70: 585–590
   Web of Science ®Google Scholar
• Ginsberg B, Perno R, Gan T J, Grichnick K, Coleman R, Glass P SA. Onset and duration of action of three doses of morphine. Anesthesia & Analgesia 1996; 82: 5130
   Google Scholar
• Egan K J, Ready L B. Patient satisfaction with intravenous PCA or epidural morphine. Can Anaesth 1994; 41: 6–11
   PubMed Web of Science ®Google Scholar
• Scott J C, Cooke J E, Stanski D R. Electroencephalographic quantification of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991; 74: 34–41
   PubMed Web of Science ®Google Scholar
• Ved S A, Dubois M, Carron H, Lea D. Sufentanil and alfentanil pattern of consumption during patient controlled analgesia: A comparison with morphine. Clin J Pain 1989; 5(Suppl 1)S63–70
   PubMedGoogle Scholar
• Lehmann K A, Gerhard A, Horrichs-Haermeyer G, Grond S, Zech D. Post operative patient controlled analgesia with sufentanil: analgesic efficacy and minimum effective concentrations. Acta Anaesth Scand 1991; 35: 221–226
   PubMed Web of Science ®Google Scholar
• Bovill J G, Sebel P S, Blackburn C L, Oei-Lim V, Heykants J J. The pharmaco-kinetics of sufentanil in surgical patients. Anesthesiology 1984; 61: 502–506
   PubMed Web of Science ®Google Scholar
• Murphy M R, Hug C C. Pharmacokinetics of intravenous morphine in patients anesthetized with enflurane-nitrous oxide. Anesthesiology 1981; 54: 187–192
   PubMed Web of Science ®Google Scholar
• Ferrante F M, Orav E J, Rocco A G, Gallo J. A statistical model for pain in patient controlled analgesia and conventional intramuscular opioid regimens. Anesth Analg 1988; 67: 457–461
   PubMed Web of Science ®Google Scholar
• Kluger M T, Owen H. Patient expectations of patient controlled analgesia. Anaesthesia 1990; 46: 1072–1074
   Web of Science ®Google Scholar
• Kramer T H, d'Amours C, Buettner B S. Pharmocodynamic model of the effects of morphine and morphine-6-glucuronide during patient-controlled analgesia. Clin Pharm Therap 1996; 59: A132
   Web of Science ®Google Scholar
• Hughes M A, Glass P SA, Jacobs J R. Context sensitive half time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76: 334–341
   PubMed Web of Science ®Google Scholar
• Pasternak G W, Bodnar R J, Clark J A, Inturrisi C E. Morphine-6-glucuronide, a potent mu agonist. Life Science 1987; 41: 2845–2849
   PubMed Web of Science ®Google Scholar
• Roos P J, Glerum J H, Meilink J W. Stability of sufentanil citrate in a portable pump reservoir, a glass container and a polyethylene container. Pharm Weekbl Sci 1992; 14: 196–200
   PubMedGoogle Scholar
• Hasselstrom J, Sawe J. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clinical Pharmacokinetics Apr, 1993; 24(4)344–354
   PubMed Web of Science ®Google Scholar